Navigation in the mega-trials waters: Reflections on the multicenter automatic defibrillator implantation trial and the antiarrhythmics versus implantable defibrillators study

American Journal of Cardiology

Volumn 83, Issue 5 B, 1999, Pages

  Farré, Jerónimo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART RATE VARIABILITY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION;

EID: 0033545656     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00965-5     Document Type: Conference Paper

References (28)

1. Gregoratos G., Cheitlin M.D., Conill A., Epstein A.E., Fellows C., Ferguson T.B. Jr, Freedman R.A., Hlatky M.A., Naccarelli G.V., Saksena S., Schlant R.C., Silka M.J. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices Executive Summary - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation) . Circulation. 97:1998;1325-1335.
2. Gregoratos G., Cheitlin M.D., Conill A., Epstein A.E., Fellows C., Ferguson T.B. Jr, Freedman R.A., Hlatky M.A., Naccarelli G.V., Saksena S., Schlant R.C., Silka M.J., Ritchie J.L., Gibbons R.J., Cheitlin M.D., Eagle K.A., Gardner T.J., Lewis R.P., O'Rourke R.A., Ryan T.J., Garson A. Jr. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation) . J Am Coll Cardiol. 31:1998;1175-1209.
3. Mehta D., Saksena S., Krol R.B., Makhija V. Comparison of clinical benefits and outcome in patients with programmable and nonprogrammable implantable cardioverter defibrillators. PACE Pacing Clin Electrophysiol. 15:1992;1279-1290.
4. Saksena S., Poczobutt-Johanos M., Castle L.W., Fogoros R.N., Alpert B.L., Kron J., Pacifico A., Griffin J., Ruskin J.N., Kehoe R.F., et al. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group. J Am Coll Cardiol. 19:1992;490-499.
5. Bardy G.H., Troutman C., Poole J.E., Kudenchuk P.J., Dolack G.L., Johnson G., Hofer B. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation. 85:1992;1689-1698.
6. Mirowski M., Reid P.R., Mower M.M., Watkins L., Gott V.L., Schauble J.F., Langer A., Heilman M.S., Kolenik S.A., Fischell R.E., Weisfeldt M.L. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 303:1980;322-324.
7. Lehmann M.H., Steinman R.T., Schuger C.D., Jackson K. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol. 62:1988;803-805.
8. Tchou P.J., Kadri N., Anderson J., Caceres J.A., Jazayeri M., Akhtar M. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med. 109:1988;529-534.
9. Fogoros R.N., Fiedler S.B., Elson J.J. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med. 107:1987;635-641.
10. Winkle R.A., Mead R.H., Ruder M.A., Gaudiani V.A., Smith N.A., Buch W.S., Schmidt P., Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 13:1989;1353-1361.
11. Fogoros R.N., Elson J.J., Bonnet C.A., Fiedler S.B., Burkholder J.A. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol. 16:1990;381-386.
12. Newman D., Sauve M.J., Herre J., Langberg J.J., Lee M.A., Titus C., Franklin J., Scheinman M.M., Griffin J.C. Survival after implantation of the cardioverter defibrillator. Am J Cardiol. 69:1992;899-903.
13. Powell A.C., Fuchs T., Finkelstein D.M., Garan H., Cannom D.S., McGovern B.A., Kelly E., Vlahakes G.J., Torchiana D.F., Ruskin J.N. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 88:1993;1083-1092.
14. Crandall B.G., Morris C.D., Cutler J.E., Kudenchuk P.J., Peterson J.L., Liem L.B., Broudy D.R., Greene H.L., Halperin B.D., McAnulty J.H., et al. Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias. J Am Coll Cardiol. 21:1993;1186-1192.
15. Saksena S. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy an international multicenter study . J Am Coll Cardiol. 23:1994;1521-1530.
16. Zipes D.P., Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation. 92:1995;59-65.
17. Wever E.F., Hauer R.N., Schrijvers G., van Capelle F.J., Tijssen J.G., Crijns H.J., Algra A., Ramanna H., Bakker P.F., Robles de Medina E.O. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors a randomized study . Circulation. 93:1996;489-496.
18. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
19. Borggrefe M., Chen X., Martinez-Rubio A., Hindricks G., Haverkamp W., Block M., Breithardt G. The role of implantable cardioverter defibrillators in dilated cardiomyopathy. Am Heart J. 127:1994;1145-1150.
20. Morady F., Harvey M., Kalbfleisch S.J., el-Atassi R., Calkins H., Langberg J.J. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 87:1993;363-372.
21. Wever E.F., Hauer R.N., van Capelle F.L., Tijssen J.G., Crijns H.J., Algra A., Wiesfeld A.C., Bakker P.F., Robles de Medina E.O. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 91:1995;2195-2203.
22. Krol R.B., Saksena S. Clinical trials of antiarrhythmic drugs in recipients of implantable cardioverter-defibrillators. Saksena S., Luderitz B. Interventional Electrophysiology. 2nd ed. 1996;365-375 Futura Publishing, Armonk (NY).
23. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with prior myocardial infarction, low ejection fraction and asymptomatic non-sustained ventricular tachycardia. N Engl J Med. 335:1996;1933-1940.
24. Wilber D.J., Olshansky B., Moran J.F., Scanlon P.J. Electrophysiological testing and nonsustained ventricular tachycardia use and limitations in patients with coronary artery disease and impaired ventricular function . Circulation. 82:1990;350-358.
25. Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel R. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 344:1994;493-498.
26. Singh S.N., Fletcher R.D., Fisher S.G., Singh B.N., Lewis H.D., Deedwania P.C., Massie B.M., Colling C., Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 333:1995;77-82.
27. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure meta-analysis of individual data from 6500 patients in randomised trials . Lancet. 350:1997;1417-1424.
28. Nisam S., Mower M. ICD trials an extraordinary means of determining patient risk? Pacing Clin Electrophysiol. 21:1998;1341-1346.